Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
EBIT Growth

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -8.272.0011.90-5.320.04

What is the latest EBIT Growth ratio of MEDICAMEN BIOTECH ?

The latest EBIT Growth ratio of MEDICAMEN BIOTECH is -8.27 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024-8.27
Mar20232.00
Mar202211.90
Mar2021-5.32
Mar20200.04

How is EBIT Growth of MEDICAMEN BIOTECH Trending?

Years EBIT Growth % Change
Mar2024 -8.27
Negative
Mar2023 2
-83.19
Mar2022 11.9
Positive
Mar2021 -5.32
Negative
Mar2020 0.04 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare EBIT Growth ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹592.5 Cr -10.8% -1.9% -2.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,363.0 Cr -2.8% -3.6% 10.8% Stock Analytics
DIVIS LABORATORIES ₹158,396.0 Cr -2.5% 1.5% 59.1% Stock Analytics
CIPLA ₹117,088.0 Cr -1.5% 0.2% 1.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,458.0 Cr -1.6% -9.2% -4.3% Stock Analytics
ZYDUS LIFESCIENCES ₹94,002.4 Cr -7.4% -5.1% 9.9% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-10.8%

-1.9%

-2.8%

SENSEX

-2.7%

-0.4%

6.4%


You may also like the below Video Courses